Joint Filer Information

Names:
Deerfield Mgmt, L.P.,  Deerfield Management Company, L.P.,
Deerfield Special Situations Fund, L.P.,
Deerfield Partners, L.P., Deerfield International Master Fund, L.P.
   
Address:
780 Third Avenue, 37th Floor
New York, NY  10017
   
Designated Filer:
James E. Flynn
   
Issuer and Ticker Symbol:
Vanda Pharmaceuticals, Inc. [VNDA]
   
Date of Earliest Transaction
Required to be Reported:
December 9, 2015
 
The undersigned, Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P. and Deerfield International Master Fund, L.P., are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Vanda Pharmaceuticals, Inc.
 
Signatures:

DEERFIELD MGMT, L.P.
 
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
        Jonathan Isler, Attorney-In-Fact
 
DEERFIELD PARTNERS, L.P.
 
By:  Deerfield Mgmt, L.P., General Partner
 
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
        Jonathan Isler, Attorney-In-Fact
 
DEERFIELD MANAGEMENT COMPANY, L.P.
 
By:  Flynn Management LLC, General Partner
 
By: /s/ Jonathan Isler
        Jonathan Isler, Attorney-In-Fact
DEERFIELD INTERNATIONAL MASTER FUND, L.P.
 
By:  Deerfield Mgmt, L.P., General Partner
 
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
        Jonathan Isler, Attorney-In-Fact
 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
 
By:  Deerfield Mgmt, L.P., General Partner
 
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
        Jonathan Isler, Attorney-In-Fact
  
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Vanda Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Vanda Pharmaceuticals 차트를 더 보려면 여기를 클릭.